February 19, 2026

Erasca, Inc. (ERAS) Stock Analysis: Clinical-Stage Innovations with a $3.92 Billion Market Cap and High Analyst Support

Erasca, Inc. (ERAS), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its focus on precision oncology. Headquartered in San Diego, California, Erasca aims to revolutionize..

Chevron Corporation (CVX) Investor Outlook: Navigating a 3.87% Yield Amidst Market Volatility

Chevron Corporation (NYSE: CVX), a stalwart in the energy sector, continues to capture investor attention with its substantial market capitalization of $367.62 billion. As a key player in the Oil..

Senseonics Holdings, Inc. (SENS) Stock Analysis: A 138.85% Potential Upside in the Healthcare Sector

Senseonics Holdings, Inc. (SENS) is making waves in the healthcare sector with its innovative approach to diabetes management. As a commercial-stage medical technology company, Senseonics focuses on the development and..

Aura Biosciences, Inc. (AURA) Stock Analysis: Assessing a Potential 300% Upside in Biotech Innovation

Aura Biosciences, Inc. (NASDAQ: AURA) stands out in the biotechnology sector, attracting significant attention from investors due to its innovative approach to treating solid tumors. A clinical-stage company, Aura is..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 303% Potential Upside in Gene Therapy Innovation

Abeona Therapeutics Inc. (NASDAQ: ABEO) stands out in the biotechnology sector with its promising advancements in gene and cell therapies, targeting life-threatening diseases. With a focus on precision medicine, the..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Unpacking the 74.59% Potential Upside

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) offers a fascinating opportunity for investors interested in the biotechnology sector, particularly those focused on innovative approaches to genetically defined diseases. With a market capitalization..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Potential 346% Upside with Innovative mRNA Therapies

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is capturing the attention of investors with its pioneering work in mRNA-based therapies and a staggering potential upside of 346.81%. The San Diego-based biotechnology..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 42.86% Potential Upside in the Cell Analysis Solutions Market

Cytek Biosciences, Inc. (NASDAQ: CTKB), a leader in the healthcare sector specializing in medical devices, has garnered notable attention from investors due to its innovative cell analysis solutions. The company,..

Rigel Pharmaceuticals (RIGL) Stock Analysis: Biotech Innovator with a 44% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a dynamic player in the biotechnology sector, is capturing investor attention with its innovative therapies and substantial growth potential. As a company focused on addressing..

USD/JPY finds buyers at key support as yield gap remains central

The pair’s rebound from support underscores how interest rate expectations continue to anchor investor positioning in the dollar versus the yen...

RECI 9.7% annual dividend yield is a standout passive income ISA option

Real Estate Credit Investments Limited has declared a third dividend of 3.0 pence per Ordinary Share for the year ending 31 March 2026...

Safestore Q1 FY2026 revenue up 6.3% at CER as occupancy and rates improve

Safestore Holdings plc reported Q1 FY2026 revenue of £61.2m, up 6.3% at constant exchange rates, driven by rate growth and contributions from new stores. Like-for-like revenue rose 4.2%, with occupancy..

Great Portland Estates fully lets phase one at City Tower above ERV

Great Portland Estates plc has fully let or placed under offer all 28,700 sq ft of phase one Fully Managed space at City Tower, securing £5.3 million in annual rent..

Reckitt Benckiser leadership to present at CAGNY 2026 conference

CEO Kris Licht and CFO Shannon Eisenhardt will present at the Consumer Analyst Group of New York (CAGNY) Conference 2026 in Orlando...

Rio Tinto reports higher EBITDA on 8% CuEq production growth

Rio Tinto PLC reported a 9% increase in underlying EBITDA to $25.4 billion for 2025, supported by an 8% rise in copper equivalent production and record iron ore output from..

Centrica reports £1.4bn EBITDA and higher dividend for 2025

Centrica reported adjusted EBITDA of £1.4bn for the year ended 31 December 2025, down from £2.3bn in 2024, reflecting lower commodity prices and challenging trading conditions...

Avation Plc to publish Interim Results on 26 February 2026

Avation PLC will release its interim results for the six months ended 31 December 2025 at 7:00 AM (UK) on 26 February 2026...

Ilika to present at Yellowstone Advisory Private Investor evening

Ilika announces that CEO Graeme Purdy and CFO Jason Stewart will present at the Yellowstone Advisory Private Investor evening on 25 February 2026 at Hudson Sandler, London...

Jubilee Metals reports 173% increase in Roan copper output for H1 FY2026

Jubilee delivered 1,246 tonnes of copper units from its Roan operations in Zambia during H1 FY2026, up 172.8% year-on-year, with total saleable copper production rising 8.7% to 1,543 tonnes...

Arbuthnot reports FY2025 profits at top of £22m–£24m range

In a pre-close update, Arbuthnot Banking Group PLC said it made good progress in the fourth quarter of 2025 and anticipates reporting pre-tax profits at the upper end of the..
Search

Funds

February 19, 2026

USD/JPY finds buyers at key support as yield gap remains central

The pair’s rebound from support underscores how interest rate expectations continue to anchor investor positioning in the dollar versus the yen...

RECI 9.7% annual dividend yield is a standout passive income ISA option

Real Estate Credit Investments Limited has declared a third dividend of 3.0 pence per Ordinary Share for the year ending 31 March 2026...

Safestore Q1 FY2026 revenue up 6.3% at CER as occupancy and rates improve

Safestore Holdings plc reported Q1 FY2026 revenue of £61.2m, up 6.3% at constant exchange rates, driven by rate growth and contributions from new stores. Like-for-like revenue rose 4.2%, with occupancy at 77.8% of current lettable area...

Great Portland Estates fully lets phase one at City Tower above ERV

Great Portland Estates plc has fully let or placed under offer all 28,700 sq ft of phase one Fully Managed space at City Tower, securing £5.3 million in annual rent at £186 per sq ft, 6.6% ahead of March 2025 ERV...

Reckitt Benckiser leadership to present at CAGNY 2026 conference

CEO Kris Licht and CFO Shannon Eisenhardt will present at the Consumer Analyst Group of New York (CAGNY) Conference 2026 in Orlando...

Rio Tinto reports higher EBITDA on 8% CuEq production growth

Rio Tinto PLC reported a 9% increase in underlying EBITDA to $25.4 billion for 2025, supported by an 8% rise in copper equivalent production and record iron ore output from Pilbara...

Centrica reports £1.4bn EBITDA and higher dividend for 2025

Centrica reported adjusted EBITDA of £1.4bn for the year ended 31 December 2025, down from £2.3bn in 2024, reflecting lower commodity prices and challenging trading conditions...

Avation Plc to publish Interim Results on 26 February 2026

Avation PLC will release its interim results for the six months ended 31 December 2025 at 7:00 AM (UK) on 26 February 2026...

Ilika to present at Yellowstone Advisory Private Investor evening

Ilika announces that CEO Graeme Purdy and CFO Jason Stewart will present at the Yellowstone Advisory Private Investor evening on 25 February 2026 at Hudson Sandler, London...

Jubilee Metals reports 173% increase in Roan copper output for H1 FY2026

Jubilee delivered 1,246 tonnes of copper units from its Roan operations in Zambia during H1 FY2026, up 172.8% year-on-year, with total saleable copper production rising 8.7% to 1,543 tonnes...

Arbuthnot reports FY2025 profits at top of £22m–£24m range

In a pre-close update, Arbuthnot Banking Group PLC said it made good progress in the fourth quarter of 2025 and anticipates reporting pre-tax profits at the upper end of the £22m to £24m consensus range for the year ended 31 December 2025...
Search

Funds

February 19, 2026

FTSE 100

Funds